Overview

Molecular Diagnostics Market is poised to value USD 31808 million by 2028 end at a CAGR of 5.4% during the forecast period 2022 to 2028.

Name: Hydroxyapatite Market: Industry Trends, Share, Size and Forecast
Brand: FutureWise Research
Price: 25.99 USD
Rating: 4.7 (43 reviews)

Molecular diagnostics involves the detection of genomic variants in order to facilitate diagnosis, subclassification, prognosis, and treatment monitoring. The goal is to apply molecular biology to medical testing by analyzing biological markers in the genome and proteome, including how cells express their genes as proteins. Diagnostic techniques such as molecular diagnostics are widely used, powerful, and sensitive methods to identify biologic markers within a genome and proteome. By using PCR-based techniques (detection of bacterial genes) and enzyme-linked immunosorbent assays [ELISAs] and proteomics), bacterial infection-specific proteins can be measured. As infectious diseases and cancer become more prevalent, the molecular diagnostics market is expected to grow further. The market is also growing due to an increase in awareness and acceptance of personalized medicines, as well as the identification and identification of biomarkers. The market is expected to be restricted by stringent regulatory requirements for the approval of new molecular diagnostics techniques during the forecast period, however. The growth of the molecular diagnostics market during the forecast period is predicted to be profitable due to the adoption of these technologies in developing economies. As a result of the COVID-19 pandemic, healthcare workflows have been disrupted around the world. A positive impact will be expected on the global molecular diagnostics market as a result of the COVID-19 outbreak. In response to the COVID-19 pandemic, the medical systems around the world are stressed, which has led to an increase in the need for diagnostic instruments as well as diagnostic service centers. Real-time polymerase chain reaction (RT-PCR) tests to detect COVID-19 have become increasingly popular due to an increase in COVID-19 cases. In addition to the increasing adoption of immunoassays and molecular diagnostics tests for COVID-19, major market players are ramping up their R&D activities to stop the pandemic.

FutureWise Market Research has instantiated a report that provides a comprehensive analysis of Molecular Diagnostics Market trends that influence the overall market growth. Furthermore, it includes elaborative insights on the graph of profitability, SWOT analysis, market share and regional business growth. Moreover, the report offers apprehension on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Molecular Diagnostics Market is predicted to achieve substantial growth by the end of the forecast period. The report explains that this business is anticipated to record a noteworthy growth rate over the forecasted timeframe. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also includes a thorough list of market segmentations along with the growth opportunities across this business vertical.

Major players included in the Molecular Diagnostics Market:
• F. Hoffmann-La Roche Ltd.
• Hologic, Inc.
• BioMérieux SA
• Abbott Laboratories
• Qiagen
• Thermo Fisher Scientific Inc.
• Siemens Healthineers AG
• Danaher Corporation
• Myriad Genetics Inc.
• Illumina Inc.
• Agilent Technologies Inc.
• Becton, Dickinson and Company
• DiaSorin S.p.A
• Grifols S.A.
• Quidel Corporation
• Genetic Signatures
• MDxHealth, Inc.
• Exact Sciences Corporation
• Biocartis NV
• TBG Diagnostics Ltd.
(Note: The list of the major players will be updated with the latest market scenario and trends)

Molecular Diagnostics Market Segmentation:
By Product
• Reagents & kits
• Instruments
o Tabletop Instruments
o Portable & PoC Instruments
• Services & Software

By Technology
• Polymerase Chain Reaction (PCR)
• Isothermal Nucleic Acid Amplification Technology (INAAT)
• DNA Sequencing & Next-Generation Sequencing (NGS)
• In Situ Hybridization (ISH)
• DNA Microarrays
• Other technologies

By Application
• Infectious Disease Diagnostics
o COVID-19
o Hepatitis
o HIV
o CT/NG
o HAI
o HPV
o Tuberculosis
o Influenza
o Other Infectious Diseases
• Oncology Testing
o Breast Cancer
o Colorectal Cancer
o Lung Cancer
o Prostate Cancer
o Other Cancers
• Genetic Tests
• Other Applications

By End User
• Diagnostic Laboratories
• Hospitals and Clinics
• Other End Users

By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Molecular Diagnostics Market Sample Video:

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Molecular Diagnostics Market By Product, By Technology, By Application, By End User and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- Product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com